Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Por Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Publicado em 2010

High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy

Por Yetukuri, Laxman, Huopaniemi, Ilkka, Koivuniemi, Artturi, Maranghi, Marianna, Hiukka, Anne, Nygren, Heli, Kaski, Samuel, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Publicado em 2011

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Por Hiukka, Anne, Ståhlman, Marcus, Pettersson, Camilla, Levin, Malin, Adiels, Martin, Teneberg, Susanne, Leinonen, Eeva S., Hultén, Lillemor Mattsson, Wiklund, Olov, Orešič, Matej, Olofsson, Sven-Olof, Taskinen, Marja-Riitta, Ekroos, Kim, Borén, Jan
Publicado em 2009